17 Nov 2025
11 months ago
1213 views
New Zealand’s Medicines Amendment Bill now allows nurse practitioners to prescribe a wider range of medicines, improving patient access and continuity of care. This change removes previous restrictions, enabling nurse practitioners to provide timely treatment directly within their scope of practice, especially benefiting communities with limited doctor access. Health Minister Simeon Brown emphasizes that this update recognizes nurse practitioners' advanced skills and enhances healthcare efficiency and outcomes.
12 Nov 2025
11 months ago
1216 views
Starting from February 1, 2026, New Zealanders will have the option to receive 12-month prescriptions for their medications, aiming to save costs and enhance convenience for those on long-term treatments. This change, introduced in Budget 2025, allows stable patients to obtain longer prescriptions, reducing the need for frequent doctor visits and potentially saving up to $105 annually in GP fees. Additionally, the government is removing ownership restrictions for pharmacists to become prescribers, enabling more accessible care and innovation in the healthcare system.
12 Nov 2025
11 months ago
1148 views
The Medicines Amendment Bill in New Zealand has lifted the prohibition on advertising medicines at medical conferences and trade shows, signaling the country's readiness for business, according to Regulation Minister David Seymour and Health Minister Simeon Brown. This change is expected to inject cash into local economies through the Red Tape Tipline and provide Kiwis with increased access to needed medicines. The move is projected to generate $90 million in revenue over the next few years, attracting major medical conferences to New Zealand and fostering economic activity.
12 Nov 2025
11 months ago
1145 views
Associate Health Minister David Seymour welcomes the passing of the Medicines Amendment Bill, which introduces the 'Rule of Two' for faster approval of medicines with recognition from two overseas jurisdictions. The streamlined verification pathway aims to increase access to medicines for New Zealanders, starting with countries like Australia, the United States, and the United Kingdom. The government prioritizes improving patient outcomes by enhancing access to medicines through initiatives like increased Pharmac funding, patient input in funding decisions, and efficient regulatory processes.
19 Aug 2025
1 year ago
1650 views
Associate Health Minister David Seymour highlights that Medsafe has been improving its efficiency in approving new medicines, with significant reductions in evaluation timeframes for both innovative and generic medicines. The implementation of initiatives like the Rule of Two and leveraging AI technology are expected to further expedite the approval processes. The focus is on ensuring faster access to vital medications for New Zealanders, with a commitment to a regulatory system that prioritizes timely approval without compromising safety.